Healthcare provider profile · identity verified

James J Vandenburg, MD

Family Practice · CLINTON, NJ · NPI 1427022607

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	571	178
Levothyroxine Sodium	Levothyroxine Sodium	355	97
Amlodipine Besylate	Amlodipine Besylate	240	74
Metoprolol Succinate	Metoprolol Succinate	196	55
Metformin Hcl Er	Metformin Hcl	194	59
Rosuvastatin Calcium	Rosuvastatin Calcium	184	65
Lisinopril	Lisinopril	140	45
Allopurinol	Allopurinol	138	37
Valsartan	Valsartan	128	35
Escitalopram Oxalate	Escitalopram Oxalate	120	34
Sertraline Hcl	Sertraline Hcl	114	34
Omeprazole	Omeprazole	110	33
Metformin Hcl	Metformin Hcl	107	32
Pantoprazole Sodium	Pantoprazole Sodium	104	35
Trazodone Hcl	Trazodone Hcl	103	25
Synthroid	Levothyroxine Sodium	100	26
Jardiance	Empagliflozin	97	25
Losartan Potassium	Losartan Potassium	96	31
Hydrochlorothiazide	Hydrochlorothiazide	95	31
Tamsulosin Hcl	Tamsulosin Hcl	93	28
Simvastatin	Simvastatin	92	25
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	86	72
Gabapentin	Gabapentin	86	17
Perindopril Erbumine	Perindopril Erbumine	75	19
Glimepiride	Glimepiride	74	22
Ezetimibe	Ezetimibe	71	21
Montelukast Sodium	Montelukast Sodium	63	23
Duloxetine Hcl	Duloxetine Hcl	61	19
Prednisone	Prednisone	61	45
Albuterol Sulfate Hfa	Albuterol Sulfate	56	34
Furosemide	Furosemide	56	20
Doxycycline Hyclate	Doxycycline Hyclate	54	46
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	16
Bupropion Xl	Bupropion Hcl	46	13
Ramipril	Ramipril	43	11
Buspirone Hcl	Buspirone Hcl	42	suppressed
Carvedilol	Carvedilol	42	17
Celecoxib	Celecoxib	42	11
Alendronate Sodium	Alendronate Sodium	41	suppressed
Azithromycin	Azithromycin	41	39
Cefdinir	Cefdinir	39	38
Candesartan Cilexetil	Candesartan Cilexetil	38	11
Ozempic	Semaglutide	38	suppressed
Meloxicam	Meloxicam	37	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	37	14
Valacyclovir	Valacyclovir Hcl	36	17
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Pravastatin Sodium	Pravastatin Sodium	35	suppressed
Farxiga	Dapagliflozin Propanediol	33	suppressed
Januvia	Sitagliptin Phosphate	33	suppressed
Famotidine	Famotidine	32	12
Esomeprazole Magnesium	Esomeprazole Magnesium	30	suppressed
Finasteride	Finasteride	30	suppressed
Mounjaro	Tirzepatide	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Fluticasone Propionate	Fluticasone Propionate	27	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	27	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Doxepin Hcl	Doxepin Hcl	26	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	15
Invokana	Canagliflozin	23	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	23	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	22	suppressed
Spiriva Respimat	Tiotropium Bromide	22	suppressed
Telmisartan	Telmisartan	22	suppressed
Atenolol	Atenolol	21	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Mometasone Furoate	Mometasone Furoate	19	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	17
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	18	suppressed
Dutasteride	Dutasteride	18	suppressed
Eliquis	Apixaban	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Alprazolam	Alprazolam	16	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	16	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	15	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	15	suppressed
Naproxen	Naproxen	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Testosterone	Testosterone	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Tramadol Hcl	Tramadol Hcl	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Linzess	Linaclotide	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Asmanex	Mometasone Furoate	12	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	12	suppressed
Desloratadine	Desloratadine	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	12	suppressed
Mupirocin	Mupirocin	12	11
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Armour Thyroid	Thyroid,pork	11	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	11	suppressed
Nystatin	Nystatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error